Premium
TREATMENT OF ADVANCED BLADDER CANCER USING C/S‐PLATINUM
Author(s) -
Harewood L. M.,
Nunn I.,
Johnson W.,
Sullivan J. R.,
Moon W. J.,
Leyden M.J.
Publication year - 1983
Publication title -
australian and new zealand journal of surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.111
H-Index - 51
eISSN - 1445-2197
pISSN - 0004-8682
DOI - 10.1111/j.1445-2197.1983.tb02458.x
Subject(s) - medicine , complete response , bladder cancer , platinum , urology , transitional cell carcinoma , carcinoma , oncology , surgery , cancer , chemotherapy , biochemistry , chemistry , catalysis
Cis ‐platinum (120 mg/m 2 ) was given to 14 patients with locally inoperable or metastatic transitional cell carcinoma of the bladder. Five patients (35%) showed a response, two complete (14%), and three partial (21%). Nine patients (65%) had no response. The median duration of survival was 3.5 months for non‐responders; 6.5 months for partial responders; and 25 months for complete responders. The side effects and implications of treatment using this agent are discussed.